topic

  • In reply: Prescribing opioids (March 2016)
    Daniel G. Tobin, MD, FACP, Rebecca Andrews, MD, FACP and William C. Becker, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 554-555; DOI: https://doi.org/10.3949/ccjm.83c.08002
  • Prescribing opioids (March 2016)
    Willie J. Pettiway, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 554-557; DOI: https://doi.org/10.3949/ccjm.83c.08001

    Readers comment on prescribing opioids (March 2016)

  • Measles: More than the rash (May 2016)
    Burke A. Cunha, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 555-556; DOI: https://doi.org/10.3949/ccjm.83c.08003

    Readers comment on recognizing the signs of measles (May 2016)

  • In reply: Acute liver failure (June 2016)
    Tavankit Singh, MD, Nancy Gupta, MD, Naim Alkhouri, MD, William D. Carey, MD and Ibrahim Hanouneh, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 557; DOI: https://doi.org/10.3949/ccjm.83c.08006
  • Acute liver failure (June 2016)
    Howard Homler, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 557; DOI: https://doi.org/10.3949/ccjm.83c.08005

    Readers comment on managing acute liver failure (June 2016)

  • Advanced-stage calciphylaxis: Think before you punch
    Arsha Sreedhar, MD, Hina A. Sheikh, MD, Charles J. Scagliotti, MD, FACS and Ranjit Nair, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 562-564; DOI: https://doi.org/10.3949/ccjm.83a.15103

    Biopsy can cause or worsen ulceration at the incision site, increasing the risk of infection and sepsis.

  • Geographic tongue
    Ceena Neena Jacob, MD, Teny Mathew John, MD, DNB and R. Jayaprakash, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 565-566; DOI: https://doi.org/10.3949/ccjm.83a.14011

    Although striking, the lesion is benign and self-limiting and rarely warrants further investigation.

  • Should patients with stable ischemic heart disease undergo revascularization?
    Michael Chenier, MD, MPH and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 567-570; DOI: https://doi.org/10.3949/ccjm.83a.15093

    The benefi t is much less clear for stable disease than for acute coronary syndromes.

  • Is a serum TSH measurement sufficient to monitor the treatment of primary hypothyroidism?
    Christian Nasr, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 571-573; DOI: https://doi.org/10.3949/ccjm.83a.15165

    Yes, the TSH level provides the information you need to manage primary hypothyroidism.

  • Your patient has chronic leukemia: Now what?
    Matt Kalaycio, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 575-581; DOI: https://doi.org/10.3949/ccjm.83gr.16002

    New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.

Pages